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Considerable progress has been made in the past decade to
define the messenger functions of Ca2 and cyclic AMP in the
actions of peptide and amine hormones [1—81. It has become
increasingly apparent that these two intracellular messengers
serve interrelated rather than separate functions, To emphasize
the interrelated nature of their actions and note the nearly
universal association of the cyclic AMP messenger system with
the calcium messenger system in the regulation of cellular
responses, the concept of synarchic (syn—together; archon—
ruler or herald) regulation was introduced [31. The central
theme of this concept is that in nearly all animal cells, Ca2 and
cyclic AMP serve together to regulate the cell response to this
class of extracellular messengers. However, rather than func-
tioning in a single stereotyped fashion, the interactions between
these two systems display an amazing plasticity. As a conse-
quence, the nature of their interactions vary from tissue to
tissue. Within this variety of expression, five general patterns of
Ca2-cyclic AMP interactions can be identified: coordinate,
hierarchical, redundant, antagonistic, and sequential. In any
given tissue, it is often possible to describe the major mode of
control as conforming to one of these five patterns. However,
when one does so, it is equally common to find that one or
another of the other patterns provides a minor theme in the
regulatory repertoire.
Within the past 3 to 4 years there has been considerable
progress in defining the more intimate details by which events
within these two messenger systems are interrelated, particu-
larly those dealing with calcium. Much of this new knowledge
has been gained from studies of hormone action in tissues other
than the kidney. Yet, if one agrees with the authors that
mammalian cells are more alike than unlike, then the knowledge
gained from studies of angiotensin II action in liver, adrenal
glomerulosa, and smooth muscle cells is directly relevant to the
action of this hormone on proximal tubular function particularly
since, in the other three tissues, the basic mechanism by which
this hormone acts appears to be the same. Likewise, studies of
the action of ACTH on adrenal glomerulosa cells may well be
relevant to those of PTH on nephron segments. Thus, rather
than review in detail the actions of angiotensin II, PTH, and
vasopressin on the renal tubule as has been done quite recently
by others [9—12], this review will summarize data obtained
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largely from studies in other tissues and then consider the
actions of kidney hormones in the light of these data and the
models of cell activation constructed from them.
Behavior of the calcium messenger system during sustained
cellular responses
Our major focus in this review will be a consideration of how
the calcium messenger system functions to couple a hormonal
stimulus to a sustained cellular response [81. Four aspects of
this type of process will be discussed: (1) the initial transducing
events which occur in the plasma membrane when hormone
interacts with its receptor, (2) the effect of the hormone on the
calcium ion concentration in the cell cytosol, (3) the effect of the
hormone on cellular calcium metabolism, and (4) the mecha-
nisms by which gain control is achieved in the calcium messen-
ger system. The latter will involve a consideration of how the
cyclic AMP messenger system interacts with the calcium mes-
senger system.
Initial membrane events
Nearly 30 years ago Hokin and Hokin [131 noted that the
addition of carbachol to slices of acinar pancreas increased the
incorporation of [32P]-phosphate into phospholipids, and, in
particular, into phosphatidylinositol. Twenty years of work led
to the repeated demonstration that in cells in which Ca2
seemed to serve a messenger function, the interaction of
extracellular messenger with its receptor induced a turnover of
phosphatidylinositides. These data led Michell [141 to propose
that P1 turnover and plasma membrane calcium gating were
linked in some cause and effect fashion. Within the past few
years improved methods for studying the metabolism of
polyphosphatidylinositols has led to an understanding of the
key role that these compounds play in the calcium messenger
system [2, 15—17]. Although several aspects remain to be
completely validated, present evidence support a model in
which phosphatidylinositol 4,5-bisphosphate (PIP2) is the criti-
cal plasma membrane component which undergoes phosphodi-
esteric cleavage when hormone interacts with receptor (Fig. 1)
As a consequence, two products are generated; diacylglycerol
(DO) and inositol 1,4,5-trisphosphate (IP3). In addition, in some
cells at least, hormone receptor interaction leads to an increase
in the rate of synthesis of phosphatidylinositol (P1) and phos-
phatidylinositol 4-phosphate (PIP), the immediate precursors of
PIP2.
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Fig. 1. Turnover of phosphatidylinositols. When a hormone (H) (or
other extracellular messenger activates this system, it appears to
produce two effects: (I) a rapid phosphodiesteric cleavage of phosphati-
dylinositol 4,5 bisphosphate (PIP2) into a water-soluble product inositol
1,4,5 trisphosphate (1P3), and a lipid soluble product, diacylglycerol(DG) which is rich in arachidonic acid; and (2) a stimulation of the
synthesis of PIP2 from phosphatidylinositol (P1) via the intermediate,
phosphatidylinositol 4-phosphate (PIP). 1P3 undergoes rapid catabolism
successively to inositol 1,4 bisphosphate (1P2), inositol 1 phosphate
(IP), and eventually free inositol (I). The DO can either be phosphoryl-
ated to phosphatidic acid (PA) which together with free I serve as
precursors of the resynthesis of P1, or it can be acted upon by
diglyceride lipase to yield monoglyceride and arachidonic acid (AA).
The latter can undergo further metabolism to prostaglandins,
leukotrienes, and/or thromboxanes, which is not considered in the
present article.
Both 1P3 and DO serve messenger functions. The 1P3 is a
water soluble messenger which enters the cytosol and induces
an increase in the rate of calcium efflux from the endoplasmic
reticulum [18—21]. It (the 1P3) is rapidly hydrolyzed succes-
sively to inositol 1,4 bisphosphate (1P2), inositol 1 phosphate
(IP) and eventually to free inositol (I) which then serves as a
substrate for the resynthesis of P1. It is presumed that in a cell
displaying a sustained response to the sustained presence of an
extracellular messenger, there is a continued high rate of P1
turnover, a sustained elevation of IP3 and hence, a depletion of
the endoplasmic reticular calcium pool.
In addition to a release of calcium from this pooi, there is in
many cells an increase in the rate of calcium influx into the cell
across the plasma membrane [22—241. The importance of this
calcium influx will be discussed below. At this point it is only
important to indicate that, to our knowledge, the link between
the P1 system and this change in plasma membrane calcium
permeability is not known. It is possible that 1P3 is the messen-
ger that regulates this process. Conversely, it is possible that a
product of DO metabolism, phosphatidic acid (PA), might serve
this function, or that the turnover of PIP2 is somehow linked to
the gating of calcium across this membrane.
The DO generated as a consequence of PIP2 hydrolysis also
serves a messenger function [7, 25—27]. It is thought to remain
in the plasma membrane and act as a positive sensitivity
modulator of a specific protein kinase, the calcium-activated,
phospholipid-dependent protein kinase or C-kinase. This kinase
is activated by Ca2, but this effect is not mediated by
calmodulin or any known calcium binding subunit. The calcium
binds directly to the enzyme. If this enzyme is extracted from
non-activated cells, it is a relatively poor protein kinase and
relatively insensitive to activation by Ca2 . However, if it is
mixed with diacyiglycerol containing at least one polyunsatu-
rated fatty acid, for example, l-oleoyl-2-acetyl-glycerol (OAO),
and a mixture of membrane phospholipids (in particular
phosphatidylserine), it is transformed into a highly active kinase
that is exquisitely sensitive to activation by Ca2. It is pre-
sumed that when hormone-receptor interaction leads to DO
production in an intact cell, the DO binds to the enzyme, causes
it to associate with phospholipids in the plasma membrane, and
shift from its calcium-insensitive to its calcium sensitive form.
Discoverers of this enzyme propose that in many cellular
systems the 1P3-induced increase in cytosolic free Ca2 acts
synergistically with the DO-dependent activation of C-kinase to
determine cellular response [7, 24—27]. Our recent data [6, 8, 20,
28—30] support this view but extend it in two ways: first, by
proposing that these two responses play distinct temporal roles
in the integrated cellular response; and second, by emphasizing
that an additional event, an increase in plasma membrane
calcium influx, plays a key role in regulating a sustained cellular
response [31]. Before considering these roles in detail, it is
necessary to discuss recent studies dealing with the hormonal-
induced changes in cytosolic-free calcium and cellular calcium
metabolism. However, before closing this discussion of C-
kinase, it is important to point out that this enzyme can be
induced to undergo a shift from its calcium-insensitive to its
calcium-sensitive form in intact cells, if these cells are treated
with either OAG or with a phorbol ester such as 12-0-tetradec-
anoyl-phorbol-13-acetate (TPA) [7, 32], valuable agents used to
explore the role of the C-kinase in the control of cellular
response.
Cytosolic calcium during cell activation
Considerable progress has also been made in our ability to
measure the calcium ion concentration in the cell cytosol. Two
methods are utilitarian, although neither is completely ideal for
this purpose. The first is that developed by Tsien [33, 34] and
uses a fluorescent derivative of EOTA, a calcium chelator,
called Quin 2, which is added to a cell suspension in its
esterified form. In this form it passes across the plasma mem-
brane into the cell where nonspecific esterases hydrolyze the
ester to its free acid, calcium binding form. This form displays
an increase in specific fluorescence when the Ca2 + concentra-
tion increases. The other method, developed in several labora-
tories [35, 36], uses a photoprotein from jellyfish, aequorin.
This protein emits light when it interacts with Ca2 in the
micromolar and submicromolar range. Its use in small cells,
such as endocrine cells or hepatocytes, requires that the cell
membrane be made reversibly permeable to the protein under
conditions where Ca2 is excluded, and then resealed into its
normal calcium-impermeable state.
Each method has its limitation; each its advantages over the
other. These will not be discussed, herein. The important fact is
that with the use of either of these methods, a number of
different investigators have found that when a large variety of
peptide and amine hormones (which had been thought to act via
the calcium messenger system) are added to appropriate target
cells, there is, as predicted, an increase in the Ca2 concentra-
tion within the cell. However, in the majority of these cases,
this increase is transient, and the Ca2 concentration returns to
or nearly to its original basal value even though the cell
continues to display its characteristic response. So these meth-
ods confirmed, on the one hand, what had long been suspected,
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that hormones do cause an increase in the Ca2 concentration
of the cytosol in their target cells, but, on the other hand,
provided the unexpected observation that such an increase is
not sustained. This unexpected observation led naturally to a
new question. The question is how does a transient message
attract a sustained cellular response. Before answering this
question, it is necessary to consider recent data concerning the
effects of hormones on cellular calcium metabolism.
Cellular calcium metabolism
Two well known studies of the effects of extracellular mes-
sengers on cellular calcium metabolism are those performed by
BorIc [23], Boric and Uchikawa [37] and Schulz [221. In the
former, the effect of parathyroid hormone on the kinetics of
calcium exchange in a kidney-derived tissue culture cell line
was determined. In the latter, the effects of carbacholamine on
calcium exchange in the acinar cells of the mammalian pancreas
were analyzed. Although the methods used were somewhat
different, the results obtained were similar in many respects. In
both cases there was an agonist-induced increase in calcium
exchange, and a slow but progressive increase in the total cell
calcium. In the case of the pancreatic cells, an analysis of the
time course of events revealed that within minutes of agonist
addition, there is a rapid net movement of calcium out of the
cell, followed by a very gradual increase back to and eventually
above the value seen in control cells. At any point along this
second phase of the response, addition of atropine (an antago-
nist of carbacholamine action) leads to a very rapid increase in
total cell calcium, and then a very gradual decline of this value
to that seen in control (untreated) cells. Based on recent
evidence, as well as considerable earlier data, a logical inter-
pretation of these results is that upon addition of agonist, a
mobilization of calcium from the endoplasmic reticulum occurs
as a consequence of an increase in 1P3 concentration. This
mobilized calcium causes a rise in the Ca2 concentration in the
cell cytosol leading to the activation of calmodulin-dependent
enzymes. One of these enzymes is the calcium pump in the
plasma membrane. As a consequence of its activation, there is
an increase in calcium efflux sufficient to cause a net effiux of
calcium from the cell. This phase lasts a few minutes and then
as the endoplasmic reticulum becomes depleted of calcium, the
rate of effiux falls, and the cell begins to gain calcium slowly.
The reason for this gain can only be an imbalance between
influx and efflux (influx > efflux), but whether this is due to a
sustained increase in influx or a decrease (after the initial
increase) in rate of efflux is not known. Likewise, the events
occurring after the addition of atropine can be explained. Upon
addition of the antagonist, 1P3 production ceases, the endoplas-
mic reticulum refills largely from the uptake of calcium by the
cell. At this point, the cell contains considerably more calcium
than normal. This extra calcium is thought to be located largely
in the mitochondria from which it is slowly released until the
cell returns to calcium balance.
Studies in hepatocytes by a number of different investigators
have provided evidence for a similar pattern of change in
cellular calcium metabolism after phenylephrine or angiotensin
II [38—44]. However, recent studies performed by Mauger et al
[451 in this system have added one important new element.
When either of these hormones is added to isolated hepato-
cytes, there is an immediate and sustained increase in the rate
of calcium influx into the cell.
In our studies of hormone action in isolated adrenal
glomerulosa cells, we have carried this type of analysis even
further by measuring the time course of change in calcium
influx, cytosolic-free calcium, and total cell calcium after angi-
otensin II addition [31]. Equally important, we have used
physiological concentrations of angiotensin II. The addition of
angiotensin II leads to an immediate (0 to 3 mm) mobilization of
calcium from the endoplasmic reticulum, a transient rise in the
intracellular Ca2 concentration (lasting 3 to 4 mm), an imme-
diate (I mm) and sustained increase in the rate of calcium influx,
and an initial fall in total cell calcium within the first 5 mm, a
slight increase to a value approximately 80% of the control
value which is then sustained for at least 40 mm. Thus, one can
recognize two phases of this response. An initial phase domi-
nated by the 1P3-induced release of Ca2 from the endoplasmic
reticulum leading to a transient rise in the Ca2 concentration in
the cell cytosol and a net efflux of calcium out of the cell, and a
second phase in which plasma membrane calcium influx re-
mains high and constant, cytosolic-free calcium is close to its
basal value and is constant, and total cell calcium is also
constant. Given the fact that influx is high and total cell calcium
constant, it is necessary to conclude that plasma membrane
calcium efflux is also high, and that efflux balances influx, that
is, in the activated cell during the sustained phase of its
response, there is a higher than normal rate of calcium cycling
across its plasma membrane (Fig. 2).
Gain control
Having reviewed hormonal effects (or other extracellular
messengers) on P1 turnover, cytosolic Ca2 concentration, and
cellular calcium metabolism, we now can consider the question
of how an apparently transient rise in cytosolic free Ca2 can
lead to a sustained cellular response. This question can be
answered in two parts: First, we consider the temporal roles of
two branches in the calcium messenger system, and second, the
link between these events and the hormonally-induced change
in cellular calcium metabolism.
One can bypass the receptor-mediated events and cause
either a transient increase in cytosolic Ca2+ concentration
and/or an activation of the C-kinase. Application of divalent
cation ionophores such as A23 187 or ionomycin can be used to
accomplish the first, and modulators of C-kinase activity, such
as OAG or TPA, the second.
With such an approach Kaibuchi et al [27], to our knowledge,
were the first to show that in the case of serotonin release from
human blood platelets, A23 187 and TPA acted synergistically in
mediating the response. lonophore alone caused a definite
increase in cytosolic calcium concentration, the phosphoryl-
ation of the protein myosin light chain—a substrate for the
calmodulin-modulated enzyme myosin light chain kinase, but a
submaximal secretory response. The addition of OAG or TPA
alone also led to a submaximal secretory response; there was no
rise in Ca2 concentration, no phosphorylation of myosin light
chain, but the phosphorylation of a specific 40K protein oc-
curred. Combined treatment with A23 187 and TPA led to a
maximal secretory response and the phosphorylation of both
proteins. This combination of drugs mimicked the effects of a
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Fig. 2. Characteristics of the two phases of cellular response when a
cell is activated by an appropriate extracellular messenger which
controls this response via calcium messenger system. In its basal state
(upper left) the cytosolic Ca2 concentration [Ca2J is low (0.1 to 0.3
/.LM), there is a significant store of calcium in the endoplasmic reticulum
(CaY), and a low but balanced rate of calcium cycling across the plasma
membrane (shaded area—lower portion of figure). The hormone recep-
tor (R) is unoccupied, there is little C-kinase in its phospholipid-bound
form CK; most of it exists in its nonactivated calcium-insensitive form
CK. There is little diacylglycerol (DG) in the membrane. During phase
1 (upper right) occurring immediately after hormone-receptor interac-
tion has initiated a response, there is a rise in the inositol trisphosphate
concentration in the cell cytosol causing a release of calcium into the
cytosol and a rise in the Ca2 concentration in this compartment. This
rise in [Ca2] leads to the activation of the plasma membrane calcium
pump and the net efflux of Ca2 out of the cell. The rise in [Ca2I
serves along with the receptor-mediated increase in the DG content of
the plasma membrane to induce the C-kinase to shift from its nonactiv-
ated form to its activated, phospholipid-associated, calcium-sensitive
form on the endoplasmic face of the plasma membrane. Hormone-
receptor interaction also leads to a prompt increase in the rate of
calcium influx into the cell across the plasma membrane. Within a few
minutes, the [Ca2]. regresses to or nearly to its basal value and the cell
enters phase 2 of its response. In this phase the endoplasmic reticulum
is depleted of calcium, the [Ca2], is near its original basal value, but
the activated C-kinase remains associated with the plasma membrane.
Also, there is a sustained high rate of Ca2 cycling across this
membrane. This high rate of cycling causes the elevation of the Ca2
concentration in a restricted, submembrane domain, [Ca2I,,, at the
endoplasmic face of the plasma membrane. The concentration of Ca2
in this domain controls the rate of expression of the activated C-kinase
enzymes bound to this face of the membrane. One can create a
pseudophase 2 response without a prior phase I occurring by treating
the cell with a combination of a calcium channel agonist, BAY K 8644
(BK), and an exogenous diacylglycerol, (OAG).
natural agonist, thrombin. These observations led to the con-
clusion that there are two pathways of information transfer in
the calcium messenger system and that they act synergistically
in mediating the cellular response to appropriate agonist.
Our own work has extended this concept by proposing that in
a cell which displays a sustained response to the sustained
presence of an agonist, the two branches of the calcium
messenger system play distinct temporal roles [6, 8]. It is our
proposal that the calmodulin branch, which is transiently acti-
vated by the transient increase in cytosolic-free calcium, is
responsible for initiating the response; and the C-kinase branch,
which is activated by the rise in DG content of the plasma
membrane, is responsible for sustaining the response.
This postulate is based on data obtained from studies on
insulin secretion, aldosterone secretion, prolactin secretion,
and smooth muscle contraction. Although the general results
and conclusions are similar from all of these systems, the most
extensive analysis has been made in the case of the hormonal
and ionic control of aldosterone secretion from adrenal
glomerulosa cells. In these cells, there is an immediate decrease
in their PIP2 content upon the addition of angiotensin 11120].
This is associated with: a prompt and sustained increase in the
contents of 1P3 and DG, an 1P3-dependent mobilization of
calcium from a dantrolene-sensitive pool (presumed to be
located in the endoplasmic reticulum), a transient rise in cyto-
solic-free Ca2 concentration (unpublished observations,
Apfeldorf, Rasmussen), a prompt and sustained increase in
calcium influx [311, a rapid decrease of total cell calcium which
is followed by a slight recovery and the maintenance of a new
steady-state, and a monotonic increase in the rate of aldoster-
one secretion to a sustained plateau. The addition of low
concentrations of A23 187 do not alter P1 metabolism but do
cause a transient rise in the cytosolic Ca2 concentration, the
mobilization of calcium from an intracellular pool due to a
direct effect on the endoplasmic reticulum, and a sustained high
rate of calcium influx [31]. Despite the fact that A23187 induces
a larger increase in cytosolic Ca2 concentration and calcium
influx than does angiotensin II, the aldosterone secretory re-
sponse is transient. The initial phase of these respective secre-
tory responses are quite similar, but after the response to
A23 187 has reached 75 to 85% of the maximal response seen
after angiotensin II, it peaks and then declines progressively to
values only slightly greater than its basal rate. In contrast, the
addition of OAG leads to no immediate changes in P1 metabo-
lism, nor cellular calcium metabolism, and a delayed, sustained
but submaximal secretory response. Combined addition of
A23187 and OAG lead to an aldosterone secretory response
which is temporarily and quantitatively similar to that seen after
angiotensin II addition.
The simplest view of these data is that the transient calcium
spike activates calmodulin-dependent enzymes which are re-
sponsible for initiating the response, but cannot, by themselves
bring about a sustained response; and that the modulation of the
C-kinase from its non-activated, calcium-insensitive form to its
activated, calcium-sensitive form, either by exogenous or
endogenous DG, complements the initiating events and is
responsible for sustaining the response. In this view, once the
cell is activated the system does not require messenger calcium.
However, this view is incorrect, the control of this system is
much more elegant than had been supposed previously. In
particular, two additional aspects of its behavior are notewothy:
The first concerns the role that the transient rise in the Ca2
lCa2 * [Ca2*lc(jns P3
(6k)[Ca21.
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concentration plays in causing the activation of the C-kinase,
and the second concerns the role that the sustained high rate of
calcium cycling plays during the sustained phase of the cellular
response (Fig. 2).
As noted above, induction of a transient rise in the Ca2
concentration in the cytosol is responsible for the transient
activation of calmodulin-regulated enzymes. However, it has an
additional function. The rise of cytosolic Ca24 acts, along with
the increase in DG content of the plasma membrane, to cause a
shift of C-kinase from its nonactivated to its activated forms
[31]. Because C-kinase molecules are not shifted from their
nonactivated to their activated state after the Ca2 transient, a
fixed amount of C-kinase remains in its activated form through-
out the sustained phase of the cellular response.
The second feature of the sustained phase is a sustained high
rate of calcium cycling across the plasma membrane. This, too,
plays a regulatory role. If either the extracellular K4 concen-
tration is reduced or a calcium channel blocker, such as
nitrendipine, is added to cells displaying a sustained response
the rate of aldosterone secretion promptly falls [311. In other
words the cycling of calcium plays a messenger function
without a significant increase in the Ca24 concentration of the
bulk cytosol. However, it can only serve this messenger role in
a cell in which C-kinase is in its activated form, that is, calcium
cycling and C-kinase are linked as a functional unit in the
plasma membrane, which controls the sustained phase of cel-
lular response. The transient rise in cytosolic Ca2 and the
sustained rise in DG determine the amount of C-kinase con-
verted to its activated, calcium-sensitive form, and the rate of
calcium cycling determines the rate at which this activated
enzyme expresses its function (Fig. 2). How this enzyme reads
this message is not yet known, but the simplest postulate is that
the rate of Ca24 cycling determines the concentration of free
Ca2 in a very restricted cellular domain at or within the
endoplasmic face of the plasma membrane, and that the mem-
brane-associated C-kinase directly responds to this elevated
Ca2 concentration rather than to this enhanced rate of cycling.
Noteworthy is the fact that one can bypass the phase I
(initial) aldosterone secretory response and create a
pseudophase 2 (sustained) response by treating the cells with a
combination of a calcium channel agonist, BAY K 8644, and an
activator of C-kinase, OAG [31]. Addition of BAY K 8644 alone
causes an increase in rate of calcium cycling across the plasma
membrane but does not cause a significant rise in the cytosolic
Ca2 concentration so it alone does not induce a phase 1
aldosterone secretory response. Nonetheless, when combined
with OAG, a prompt and sustained secretory response is
observed which is considerably more rapid in onset and dis-
plays a higher sustained plateau than that sustained response
induced by OAG alone, but is only 50% of the maximal
response seen when a phase 1 response precedes a phase 2
response.
Of particular interest is the fact that in the same cell type,
adrenal glomerulosa cells, another peptide hormone, ACTH,
also uses Ca24 as a messenger and induces a sustained cellular
response, but does so without activating the C-kinase branch of
the calcium messenger system [46, 47]. The mechanism by
which gain control is achieved during the action of ACTH is
equally as elegant as that by which it is achieved during
angiotensin II action (Fig. 3). Rather than using the C-kinase
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Fig. 3. Comparison of the flow of information when angiotensin II (left)
and ACTH (right) act on adrenal glomerulosa cells to induce a
sustained cellular response. When All acts, information flows through
two (or three) branches of the system. Hormone-receptor interaction
leads to the generation of diacylglycerol (DG), inositol trisphosphate
(InP3), and an increase in plasma membrane calcium influx. The rise in
1P3 leads to the mobilization of Ca2 from the endoplasmic reticulum
which leads to a rise in the Ca2 concentration in the cytosol. This rise
in Ca2* concentration initiates the activation of calmodulin-regulated
enzymes (CaM E). Because the rise in Ca2 concentration is transient,
the activation of the CaM E is also transient, and only a transient
aldosterone secretory response is induced by the flow of information
through this branch. The rise in the DO content of the plasma
membrane along with the transient increase in the Ca2 concentration
of the cell cytosol induces a shift of C-kinase from its nonactivated to its
activated form. Regulation of the expression of this enzyme depends on
plasma membrane Ca2 cycling (not shown). If only this pathway is
activated, a slowly developing and submaximal response is seen.
However, when the flow of information via both branches is integrated,
temporally, a maximal, sustained secretory response is observed. In the
case of ACTH two surface receptors are involved, R1 and R2. Binding
of ACTH to R2 increases plasma membrane calcium influx which causes
a transient increase in the cytosolic Ca2 concentration, the activation
of calmodulin-dependent enzymes, and a transient secretory response.
Binding of ACTH to R1 leads to an activation of adenylate cyclase, a
rise in cyclic AMP content, the activation of cyclic AMP-dependent
protein kinase (A-kinase), and a sustained but submaximal secretory
response. If both receptors are activated simultaneously, information
flows via both branches and an additional effect is seen; the increase in
calcium influx induced by ACTH binding to R2 acts to enhance the
effect of the ACTH (bound to R1) on adenylate cyclase activation. Also
not depicted is the increased activity of the cyclic AMP-dependent
protein kinase which, in turn, increases the sensitivity of CaM . E to
activation by calcium. When information flows simultaneously via both
branches, an integrated cellular response is seen.
control device, the cell activates the cyclic AMP messenger
system to modulate events in the calcium messenger system. In
acting on these cells, ACTH works via two classes of surface
receptors. One class, a high affinity but low capacity one, is
linked to calcium gating in the plasma membrane; the other
class, a lower affinity, but high capacity class, is linked to
adenylate cyclase. The intracellular events occurring as a
consequence of ACTH-receptor interactions are linked in two
ways. The influx of Ca2 resulting from the binding of ACTH to
/\
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its first class of receptors, sensitizes the adenylate cyclase
system to activation by ACTH bound to its second class of
receptors. Hence, Ca2 + influx, a process controlled by the high
affinity class of receptors, acts as a positive feedforward mod-
ulator of the activation of adenylate cyclase, a process con-
trolled by the lower affinity class of receptors. The second type
of interaction between Ca2 and cyclic AMP is at the level of
calcium messenger function. A rise in cyclic AMP concentra-
tion, acting via cyclic AMP-dependent protein kinase, leads to
the phosphorylation of one or more calcium-regulated, calmod-
ulin-dependent response elements, and alters in a positive way,
the sensitivity of these response elements to activation by
Ca2 . The cyclic AMP-dependent phosphorylation of these
response elements makes them more sensitive to activation by
Ca2, that is, they are turned on by lower concentrations of
Ca2 , concentrations similar to those found normally in the cell
cytosol. Hence, cellular response is sustained in the face of a
transient increase in the Ca2 concentration of the cell cytosol
because of the positive sensitivity modulation of calmodulin-
dependent response elements by cyclic AMP-dependent protein
kinase (a detailed discussion of the concept and importance of
sensitivity modulation has been presented elsewhere [4]). In
these cells the action of ACTH involves the synarchic messen-
gers, Ca2 and cyclic AMP, interacting in both hierarchical and
sequential patterns to achieve an integrated cellular response.
Although these two different mechanisms can operate in-
dependently of one another, they can also act synergistically in
the sense that in the adrenal cells, as well as a variety of other
cells, a rise in the cyclic AMP concentration enhances the
response induced by events in the C-kinase branch of the
calcium messenger system. Exactly how cyclic AMP influences
events in this C-kinase branch is not known, but it is already
clear that its action involves effects other than, or in addition to,
effects on cellular calcium fluxes and concentrations.
Action of renal hormone. Since the present series of papers
focuses on renal cell metabolism rather than transport, our
major discussion of the action of renal hormones will be
confined to a consideration of the actions of PTH and angioten-
sin II on the process of gluconeogenesis in the cells of proximal
renal tubules. There are a number of recent reviews which
summarize earlier work in this field [9, 10], and discuss its
relevance to the effects of these hormones on various transport
processes [10—12]. In addition, the possible roles of cyclic AMP
and Ca2 in the action of vasopressin in transporting epithelial
has been discussed throughly recently [11].
Angiotensin II and renal gluconeo genesis. The available data
argue that this hormone acts to control renal gluconeogensies in
much the same way it acts to regulate hepatic glucose produc-
tion and aldosterone secretion in adrenal glomerulosa cells.
Hormone addition to isolated renal tubules leads to a hydrolysis
of PIP2 [48], a calcium-dependent increase in glucose formation
[49] without a rise, but in fact a fall [50], in the cyclic AMP
content of the tubules. There are no published data which
evaluate the respective roles of the calmodulin and C-kinase
branches of the calcium messenger system in angiotensin II-
mediated gluconeogenesis, but it is reasonable to predict that
each branch will play a different temporal role in regulating this
tissue response.
PTH and renal gluconeogenesis
Considerably more information is available concerning the
effects of PTH on renal gluconeogenesis. In this case, it is quite
clear that cyclic AMP plays an important messenger function
[50—53]. Likewise, there is considerable data showing that Ca2
is involved [53, 54], although opinion is divided as to whether or
not Ca2 serves a classic messenger role in PTH action. There
are at least two possible models either of which could account
for the available data. Either Ca2 + is a true messenger in the
sense described for Ca2 in the actions of angiotensin II and
ACTH on adrenal glomerulosa cells or Ca2 + is required for the
expression of cyclic AMP action. In such a model system one of
the effects of cyclic AMP would be to act as a positive
sensitivity modulator of calcium-regulated enzymes. In this
regard, it is interesting that the stimulatory effect of exogenous
cyclic AMP on glucose formation from certain substrates, that
is, citrate, a-ketoglutarate, succinate, and malate depends on
calcium.
Most interesting data concerning PTH action are those show-
ing that low concentrations of Ca2 + may be necessary for or
enhance the activation of the adenylate cyclase by P1'H: a
situation reminiscent of that described for ACTH action in the
adrenal cortex [55—57]. For this analogy to hold, one would
have to postulate that there are two classes of PTH receptors on
the renal tubular cell: a high affinity, low capacity class linked to
Ca2 + entry, and a lower affinity high capacity class linked to the
cyclase. The general belief is that only a single class of PTH
receptors exists, but this opinion is not unanimous. Parenthet-
ically, a similar uncertainty existed for a long time in the case of
ACTH receptors on adrenal cells. Further analogies exist
between ACTH action in glomerulosa cells and PTH action on
renal cells. In both cases many of the effects of exogenous
cyclic AMP depend on the presence of Ca2t On the other
hand, there are reports that PTH stimulates P1 turnover in renal
cells, an action not produced by ACTH. However, the studies
done to date with PTH address only the issue of P1 synthesis
[48, 58—60]. No one, to our knowledge, has shown that PTH
stimulates the hydrolysis of PIP2 and the production of 1P3 and
DG. Until such experiments are performed, the question of
whether or not PTH mediates some of its effects via the
C-kinase branch of the calcium messenger system remains an
open one.
Parenthetically, it would be of considerable general interest if
the same peptide hormone brought about the activation of both
the cyclic AMP messenger system and the complete calcium
messenger system, as do catecholamines acting on the liver,
that is, the calcium messenger system is linked to the alpha
receptor and the cyclic AMP messenger system to beta recep-
tor. If PTH were found to activate the calcium messenger
system, this would be very strong indirect evidence for the
existence of two classes of PTH receptors. In considering this
possibility, it should also be made explicit that when ACTH
binds to its high affinity class of receptors, it brings about an
increase in the rate of plasma membrane calcium influx without
activating PIP2 hydrolysis. In this case, the only recognized
change in cellular calcium metabolism is a sustained increase in
the rate of calcium cycling across the plasma membrane. In
contrast, when catecholamines act in the liver cell, activation of
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alpha receptors leads to PIP. hydrolysis and a similar sequence
of events as those seen in the case of angiotensin II action. Thus,
certain hormone receptors can activate the full calcium messenger
system, and others only a single component of it. The molecular basis
for this selective activation of a single component is not yet known.
The relevance of this discussion to the mechanism of action of 11TH
on the renal tubule is that either model of PTH action is possible
based on the available data. The experimental methods are now
available with which to test these alternative models in renal cells.
From such experiments, it should be possible to define which model
more adequately accounts for the control of renal gluconeogenesis by
11TH,
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